Papers

6 results
EXTRA-SHORT IMPLANTS MAY BE A VIABLE ALTERNATIVE TO LONGER IMPLANTS WITH BONE AUGMENTATION IN ATROPHIC MAXILLARY AND MANDIBULAR RIDGES.
Radi IA, Hytham A - The journal of evidence-based dental practice, March 14, 2023 0 citations
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6‍ mm), longer implants (≥ 8‍ mm)
O
bone augmentation
Not all Desensitizing Toothpastes Perform Equally Well.
Balevi B - The journal of evidence-based dental practice, September 15, 2020 2 citations
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
Li DF, Tulahong A, Uddin MN, Zhao H, Zhang H - Mathematical biosciences and engineering : MBE, September 15, 2021 2 citations
P
E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6
I/C
O
survival prognosis, immune infiltrations, diagnostic efficacy
The Effect of Tai Chi for Improving Sleep Quality: A Systematic Review and Meta-analysis.
Li H, Chen J, Xu G, Duan Y, Huang D, Tang C, Liu J - Journal of affective disorders, July 16, 2020 35 citations
P
patients with sleep complaints
I/C
Tai Chi, non-treatment and active treatment groups
O
Pittsburgh Sleep Quality Index (PSQI)
Associations between the use of red yeast rice preparations and adverse health outcomes: An umbrella review of meta-analyses of randomized controlled trials.
Ma ZY, Yang SP, Li Y, Xu TT, Yang YL, Yang HY, Li HB, Zhou LJ, Diao Y, Li SY - Journal of integrative medicine, February 28, 2024 0 citations
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes
Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis.
Lv X, Qi J, Zhou M, Shi B, Cai C, Tang Y, Pan T, Han Y - Critical reviews in oncology/hematology, April 05, 2020 7 citations
P
8050 patients
I/C
Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone
O
proportion of patients who respond to therapies
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.